Search
for
Sort by
Research 61–90 of 1000+
- Novel Treatment Using Low-Dose Naltrexone for Lichen Planopilaris.
- TREATMENT SUCCESS IN THREE ANDEAN BEARS (<i>TREMARCTOS ORNATUS</i>) WITH ALOPECIA SYNDROME USING OCLACITINIB MALEATE (APOQUEL®)
- Familial and Sporadic Porphyria Cutanea Tarda
- Pregnancy and the Skin
- A clinical study of skin changes in geriatric population
- Clinical, morphological and immunohistochemical characterization of cutaneous lymphocytosis in 23 cats
- Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- Zinc‐responsive dermatosis in goats suggestive of hereditary malabsorption: two field cases
- Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
- Demodicosis in ferrets (Mustela putorius furo)
- Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Sensitive skin
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Skin disorders in elderly subjects
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Enhancing hair growth in male androgenetic alopecia by a combination of fractional CO2 laser therapy and hair growth factors
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Pregnancy and Skin
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Menopause, skin and common dermatoses. Part 2: skin disorders
- Cutaneous toxicities of new treatments for melanoma
- Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia
- The role of lysophosphatidic acid in the physiology and pathology of the skin
- Physiologic changes and dermatoses of pregnancy
- Feline superficial pyoderma: a retrospective study of 52 cases (2001–2011)
- Feline acne and results of treatment with mupirocin in an open clinical trial: 25 cases (1994–96)